GEN:NYE-Genesis Healthcare Inc. (USD)

EQUITY | Software - Infrastructure | New York Stock Exchange

Last Closing

USD 22.1

Change

+0.20 (+0.91)%

Market Cap

USD 0.52B

Volume

2.52M

Analyst Target

USD 1.38
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Genesis Healthcare Inc is a post-acute care provider. The Company operates skilled nursing centers and assisted/senior living communities. The Company also supplies rehabilitation and respiratory therapy.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-03-27 )

Largest Industry Peers for Software - Infrastructure

Symbol Name Price(Change) Market Cap
MSFT Microsoft Corporation

+7.28 (+1.82%)

USD 3,185.73B
ADBE Adobe Systems Incorporated

+4.12 (+0.87%)

USD 213.75B
SNPS Synopsys Inc

+13.55 (+2.56%)

USD 90.64B
PANW Palo Alto Networks Inc

+2.63 (+0.91%)

USD 90.17B
CRWD Crowdstrike Holdings Inc

+6.05 (+2.03%)

USD 76.35B
FTNT Fortinet Inc

+0.15 (+0.23%)

USD 52.12B
KSPI Joint Stock Company Kaspi.kz

+3.80 (+3.27%)

USD 43.40B
ZS Zscaler Inc

+2.24 (+1.28%)

USD 29.21B
MDB MongoDB

+17.67 (+4.83%)

USD 25.89B
CHKP Check Point Software Technolog..

-1.75 (-1.14%)

USD 19.31B

ETFs Containing GEN

BUG:XETRA Global X Cybersecurity UC.. 6.10 % 0.00 %

+0.30 (+-0.64%)

USD 0.02B
BUGG:AU Global X Cybersecurity ET.. 6.05 % 0.00 %

-0.07 (-0.64%)

N/A
BUGU:SW Global X Cybersecurity UC.. 5.68 % 0.00 %

+0.12 (+-0.64%)

USD 0.03B
CBRS:XETRA First Trust Nasdaq Cybers.. 3.20 % 0.00 %

+0.81 (+-0.64%)

USD 0.43B
HACK:AU Betashares Global Cyberse.. 3.17 % 0.00 %

-0.08 (-0.64%)

USD 0.94B
BIGT:LSE L&G Pharma Breakthrough U.. 0.00 % 0.00 %

+11.00 (+-0.64%)

USD 0.02B
XSDR:LSE Xtrackers MSCI Europe Hea.. 0.00 % 0.00 %

+193.00 (+-0.64%)

USD 0.14B
USPY:XETRA L&G Cyber Security UCITS .. 0.00 % 0.00 %

+0.64 (+-0.64%)

USD 2.62B
RCRS:XETRA Rize UCITS ICAV - Rize Cy.. 0.00 % 0.00 %

+0.11 (+-0.64%)

USD 0.13B

Market Performance

  Market Performance vs. Industry/Classification (Software - Infrastructure) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -3.16% 42% F 40% F
Dividend Return 0.55% 80% B- 35% F
Total Return -2.61% 44% F 40% F
Trailing 12 Months  
Capital Gain 32.81% 65% D 81% B-
Dividend Return 3.00% 100% F 47% F
Total Return 35.82% 66% D+ 81% B-
Trailing 5 Years  
Capital Gain 1,434.72% 96% N/A 98% N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 1,434.72% 96% N/A 98% N/A
Average Annual (5 Year Horizon)  
Capital Gain 2,136.14% 99% N/A 99% N/A
Dividend Return 2,136.34% 99% N/A 99% N/A
Total Return 0.20% 29% F 7% C-
Risk Return Profile  
Volatility (Standard Deviation) 3,805.55% 3% F 1% F
Risk Adjusted Return 56.14% 88% B+ 85% B
Market Capitalization 0.52B 86% B+ 94% A

Key Financial Ratios

  Ratio vs. Industry/Classification (Software - Infrastructure) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 9.88 90% 70%
Price/Book Ratio 5.75 39% 19%
Price / Cash Flow Ratio 18.37 40% 16%
Price/Free Cash Flow Ratio 14.34 35% 18%
Management Effectiveness  
Return on Equity 74.95% 96% 98%
Return on Invested Capital 22.71% 87% 90%
Return on Assets 6.25% 84% 89%
Debt to Equity Ratio 433.14% 3% 5%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Underpriced compared to earnings

The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.